In the United States, latent tuberculosis infection (LTBI) detection in correctional settings is a public health priority. Interferon gamma release assay (IGRA)-based LTBI screening was introduced in New York City jails in 2011 to 2012, replacing historically used tuberculin skin testing (TST), which was associated with substantial incomplete screening rates. This retrospective, cross-sectional study evaluated LTBI screening outcomes and correlates of positivity in 40,986 persons newly incarcerated in 2011 to 2013. Of 35,090 eligible patients tested (96.4%), final results were 6.3% positive, 93.4% negative, and 0.2% indeterminate. In multivariable regression modeling, sex, age, race/ethnicity, nativity, marital status, prior jail incarceration, and HIV status were correlated with positivity. IGRA-based screening yielded high screening and low indeterminate test rates and may be recommended in correctional and other settings where TST is currently used.
AlamiN. N., YuenC. M., MiramontesR. M., PrattR., PriceS. F., NavinT. R. (2013). Trends in tuberculosis-United States, 2013. Morbidity and Mortality Weekly Report, 63, 229–233.
2.
American Thoracic Society. (2000). Targeted tuberculin testing and treatment of latent tuberculosis infection. American Journal of Respiratory and Critical Care Medicine, 161, S221–S247.
3.
BanachD. B., HarrisT. G. (2011). Indeterminate QuantiFERON-TB Gold results in a public health clinic setting. International Journal of Tuberculosis and Lung Disease, 15, 1623–1630.
4.
CantwellM. F., McKennaM. T., McCrayE., OnoratoI. M. (1998). Tuberculosis and race/ethnicity in the United States: Impact of socioeconomic status. American Journal of Respiratory and Critical Care Medicine, 157, 1016–1020.
ConeJ. E., HarrisonR., KatzE., ChanJ., DewsnupD., OsorioA. M. (2000). Tuberculosis transmission to prison employees during an outbreak among prisoners at two California prisons. Journal of Healthcare Safety, Compliance & Infection Control, 4, 75–79.
7.
ConklinT. J., LincolnT., TuthillR. W. (2000). Self-reported health and prior health behaviors of newly admitted correctional inmates. American Journal of Public Health, 90, 1939–1941.
8.
DielR., LoddenkemperR., NienhausA. (2010). Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: A metaanalysis. Chest, 137, 952–968.
9.
DyeC., ScheeleS., DolinP., PathaniaV., RaviglioneM. C. (1999). Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. Journal of the American Medical Association, 282, 677–686.
10.
FazelS., BaillargeonJ. (2011). The health of prisoners. Lancet, 377, 956–965.
11.
FreudenbergN. (2001). Jails, prisons, and the health of urban populations: A review of the impact of the correctional system on community health. Journal of Urban Health, 78, 214–235.
12.
GlaserJ. B., GreifingerR. B. (1993). Correctional health care: A public health opportunity. Annals of Internal Medicine, 118, 139–145.
HammettT. M., HarmonM. P., RhodesW. (2002). The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. American Journal of Public Health, 92, 1789–1794.
15.
HorsburghC. R.Jr (2004). Priorities for the treatment of latent tuberculosis infection in the United States. New England Journal of Medicine, 350, 2060–2067.
16.
HuebnerR. E., ScheinM. F., BassJ. B.Jr (1993). The tuberculin skin test. Clinical Infectious Diseases, 17, 968–975.
17.
IrohP. A. (2015, 3). Cost comparison and clinical evaluation of a blood test for tuberculosis (TB) in a correctional setting. Poster presented at the Eighth Academic and Health Policy Conference on Correctional Health, Baltimore, MD.
18.
JeonC. Y., MurrayM. B. (2008). Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. PLoS Medicine, 5, e152.
19.
JonesT. F., WoodleyC. L., FountainF. F., SchaffnerW. (2003). Increased incidence of the outbreak strain of Mycobacterium tuberculosis in the surrounding community after an outbreak in a jail. Southern Medical Journal, 96, 155–157.
20.
JoshiM., MonsonT. P., WoodsG. L. (2012). Use of interferon-gamma release assays in a health care worker screening program: Experience from a tertiary care centre in the United States. Canadian Respiratory Journal, 19, 84–88.
21.
KulkarniS. P., BaldwinS., LightstoneA. S., GelbergL., DiamantA. L. (2010). Is incarceration a contributor to health disparities? Access to care of formerly incarcerated adults. Journal of Community Health, 35, 268–274.
22.
LeeJ., VlahovD., FreudenbergN. (2006). Primary care and health insurance among women released from New York City jails. Journal of Health Care for the Poor and Underserved, 17, 200–217.
23.
MazurekG. H., JerebJ., VernonA., LoBueP., GoldbergS., CastroK. ., & IGRA Expert Committee. (2010). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection—United States, 2010. Morbidity and Mortality Weekly Report, 59, 1–25.
PaiM., ZwerlingA., MenziesD. (2008). Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Annals of Internal Medicine, 149, 177–184.
27.
Qiagen. (2015). QuantiFERON-TB Gold In-Tube package insert. Valencia, CA.
28.
SantinM., MunozL., RigauD. (2012). Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: A systematic review and meta-analysis. PLoS One, 7, e32482.
29.
SchlugerN. W., BurzynskiJ. (2010). Recent advances in testing for latent TB. Chest, 138, 1456–1463.
30.
SchwartzI. S., BachP. J., RoscoeB., MajuryA., HopmanW. M., EllisE.…WobeserW. L. (2014). Interferon-gamma release assays piloted as a latent tuberculosis screening tool in Canadian federal inmates. International Journal of Tuberculosis and Lung Disease, 18, 787–792.
31.
SlaterM. L., WellandG., PaiM., ParsonnetJ., BanaeiN. (2013). Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. American Journal of Respiratory and Critical Care Medicine, 188, 1005–1010.
32.
SosaL. E., LobatoM. N., CondrenT., WilliamsM. N., HadlerJ. L. (2008). Outbreak of tuberculosis in a correctional facility: Consequences of missed opportunities. International Journal of Tuberculosis and Lung Disease, 12, 689–691.
33.
StazeskyR., HughesJ., VentersH. (2012). Implementation of an electronic health record in the New York City jail system (Issue paper). Community Oriented Correctional Health Services. Retrieved from http://www.cochs.org/files/hieconf/implementation-ecw-new-york.pdf
34.
StennisN. L., TrieuL., AhujaS. D., HarrisT. G. (2014). Estimated prevalence of tuberculosis infection among a New York City clinic population using interferon-gamma release assays. Open Forum Infectious Diseases, 1. doi:10.1093/ofid/ofu047.
35.
TrajmanA., SteffenR. E., MenziesD. (2013). Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: An overview of the evidence. Pulmonary Medicine, 2013. doi:10.1155/2013/601737.
36.
TufarielloJ. M., ChanJ., FlynnJ. L. (2003). Latent tuberculosis: Mechanisms of host and bacillus that contribute to persistent infection. Lancet Infectious Diseases, 3, 578–590.
WangE. A., WhiteM. C., JamisonR., GoldensonJ., EstesM., TulskyJ. P. (2008). Discharge planning and continuity of health care: Findings from the San Francisco County Jail. American Journal of Public Health, 98, 2182–2184.
ZwerlingA., BehrM. A., VermaA., BrewerT. F., MenziesD., PaiM. (2011). The BCG World Atlas: A database of global BCG vaccination policies and practices. PLoS Medicine, 8, e1001012.
